who was henrietta lacks

Henrietta Lacks was a Black American woman whose cancer cells, taken without her knowledge in 1951, became the first “immortal” human cell line and transformed modern medicine.

Quick Scoop: Who she was

• Born Loretta Pleasant on August 1, 1920, in Roanoke, Virginia, later known as Henrietta Lacks.

• A poor Black tobacco farmer and mother of five who grew up in the Jim Crow South.

• Moved with her family to Maryland, where her husband worked in a steel mill near Baltimore.

• Died at just 31 years old on October 4, 1951, from an aggressive cervical cancer treated at Johns Hopkins Hospital.

What happened to her cells (HeLa)

When Henrietta went to Johns Hopkins in 1951 because of severe vaginal bleeding, doctors found a large malignant tumor on her cervix.

During treatment, they took a small sample of her cancer cells and passed them to a researcher, without telling her or asking consent, which was common (but ethically troubling) practice at the time.

Those cells did something no human cells had done in the lab before:

• They kept dividing instead of dying after a few days.
• Researchers isolated and grew them into a stable cell line.
• They labeled the sample “HeLa” from the first two letters of He nrietta and La cks.

HeLa cells became the first “immortal” human cell line, able to reproduce indefinitely under the right conditions.

Why HeLa cells changed medicine

HeLa cells have been used in an enormous range of scientific breakthroughs.

A few key examples:

• Development of the polio vaccine.

• Research into cancer, viruses, and radiation effects.

• Advances in IVF, gene mapping, and many modern drugs, including some used for Parkinson’s and leukemia.

• Space research, toxicology testing, and basic cell biology experiments worldwide.

HeLa became so widespread that it’s estimated that many thousands of scientific papers and countless experiments have relied on those cells.

Ethics, consent, and her legacy

For decades, Henrietta’s name and story were hidden.
Researchers used pseudonyms like “Helen Lane” or “Helen Larsen” to obscure where HeLa came from, and her real identity only became widely known in the 1970s.

Her case raised major ethical questions:

• No informed consent: She and her family were never asked for permission to use her cells.

• No compensation: For years, companies and institutions made money and prestige from HeLa-based research while her family remained poor.

• Privacy and genetic rights: Later genome work using HeLa cells sparked debates about who controls a person’s genetic information.

These controversies helped push reforms in research ethics (such as stronger informed-consent norms) and led the U.S. National Institutes of Health to give her family a say over access to HeLa genomic data.

In today’s news and culture

Henrietta Lacks is now widely recognized as a symbol of both scientific progress and medical exploitation.
Her life and impact were popularized by Rebecca Skloot’s best-selling book The Immortal Life of Henrietta Lacks and its 2017 film adaptation starring Oprah Winfrey.

In recent years, her family has brought lawsuits against biotech and pharma companies for profiting from HeLa cells without permission.
They reached notable settlements, including one in 2021 and another with a major drug company announced in early 2026.

Today, institutions honor her with memorials, lectures, and ethics discussions, emphasizing that behind the “immortal” cell line was a real woman with a family, a history, and rights that were ignored.

Information gathered from public forums or data available on the internet and portrayed here.